Literature DB >> 12384870

Radiofrequency ablation of primary and metastatic liver tumors.

Steven A Curley1, Francesco Izzo.   

Abstract

Worldwide, hepatocellular carcinoma (HCC) is one of the most common and deadly solid cancers. At least one million new patients are diagnosed annually with this cancer. Incidence in non-Western countries is related to infections of hepatitis B virus and dietary ingestion of aflatoxins, whereas in Western countries alcohol-related cirrhosis and chronic hepatitis C virus infection are leading causes of HCC. In the United States, approximately 155,000 new cases of cancer of the liver and bile duct occur annually, with the majority being colorectal metastases.

Entities:  

Mesh：

Year:  2002        PMID： 12384870

Source DB:  PubMed          Journal:  Surg Technol Int        ISSN： 1090-3941


  7 in total

1.  Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: prognosis and outcomes.

Authors:  Tan To Cheung; Kelvin K Ng; Kenneth S Chok; See Ching Chan; Ronnie T Poon; Chung Mau Lo; Sheung Tat Fan
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

2.  Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome.

Authors:  Vlasios S Sotirchos; Lydia M Petrovic; Mithat Gönen; David S Klimstra; Richard K G Do; Elena N Petre; Alessandra R Garcia; Afsar Barlas; Joseph P Erinjeri; Karen T Brown; Anne M Covey; William Alago; Lynn A Brody; Ronald P DeMatteo; Nancy E Kemeny; Stephen B Solomon; Katia O Manova-Todorova; Constantinos T Sofocleous
Journal:  Radiology       Date:  2016-03-24       Impact factor: 11.105

3.  Periportal low attenuation associated with liver metastasis from colorectal cancer: evaluation using multi-detector-row CT with pathological correlation.

Authors:  Ryo Takaji; Shunro Matsumoto; Maki Kiyonaga; Yasunari Yamada; Hiromu Mori; Yukio Iwashita; Masayuki Ohta; Masafumi Inomata; Naoki Hijiya; Masatsugu Moriyama; Hajime Takaki; Kengo Fukuzawa; Hirotoshi Yonemasu
Journal:  Jpn J Radiol       Date:  2016-10-25       Impact factor: 2.374

4.  Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies.

Authors:  Constantinos T Sofocleous; Sandeep Garg; Lydia M Petrovic; Mithat Gonen; Elena N Petre; David S Klimstra; Stephen B Solomon; Karen T Brown; Lynn A Brody; Ann M Covey; Ronald P Dematteo; Lawrence Schwartz; Nancy E Kemeny
Journal:  Ann Surg Oncol       Date:  2012-07-03       Impact factor: 5.344

5.  Radiofrequency ablation of recurrent cholangiocarcinoma after orthotopic liver transplantation -- a case report.

Authors:  Rakesh Rai; Derek Manas; John Rose
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

6.  Chemopreventive effect of 18β-glycyrrhetinic acid via modulation of inflammatory markers and induction of apoptosis in human hepatoma cell line (HepG2).

Authors:  Syed Kazim Hasan; Aisha Siddiqi; Sana Nafees; Nemat Ali; Summya Rashid; Rashid Ali; Ayaz Shahid; Sarwat Sultana
Journal:  Mol Cell Biochem       Date:  2016-04-26       Impact factor: 3.396

Review 7.  Radio-frequency ablation-based studies on VX2rabbit models for HCC treatment.

Authors:  Sabrina Bimonte; Maddalena Leongito; Mauro Piccirillo; Cristina de Angelis; Claudia Pivonello; Vincenza Granata; Francesco Izzo
Journal:  Infect Agent Cancer       Date:  2016-08-12       Impact factor: 2.965
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.